249 related articles for article (PubMed ID: 18000515)
21. Anti-CD20 monoclonal antibody in acute life threatening haemolytic anaemia complicating childhood onset SLE.
Abdwani R; Mani R
Lupus; 2009 Apr; 18(5):460-4. PubMed ID: 19318402
[TBL] [Abstract][Full Text] [Related]
22. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
Dejica DI; Manea EM
Roum Arch Microbiol Immunol; 2006; 65(1-2):66-74. PubMed ID: 17877113
[TBL] [Abstract][Full Text] [Related]
23. Drug-induced lupus erythematosus.
Vedove CD; Del Giglio M; Schena D; Girolomoni G
Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
[TBL] [Abstract][Full Text] [Related]
24. The B cell in systemic lupus erythaematosus: a rational target for more effective therapy.
Driver CB; Ishimori M; Weisman MH
Ann Rheum Dis; 2008 Oct; 67(10):1374-81. PubMed ID: 17720723
[TBL] [Abstract][Full Text] [Related]
25. A dose-escalation study of rituximab for treatment of systemic lupus erythematosus and Evans' syndrome: immunological analysis of B cells, T cells and cytokines.
Tamimoto Y; Horiuchi T; Tsukamoto H; Otsuka J; Mitoma H; Kimoto Y; Nakashima H; Muta K; Abe Y; Kiyohara C; Ueda A; Nagasawa K; Yoshizawa S; Shimoda T; Harada M
Rheumatology (Oxford); 2008 Jun; 47(6):821-7. PubMed ID: 18397955
[TBL] [Abstract][Full Text] [Related]
26. Treatment. Disease-modifying therapies.
Lieberman JD; Schatten S
Rheum Dis Clin North Am; 1988 Apr; 14(1):223-43. PubMed ID: 3041490
[TBL] [Abstract][Full Text] [Related]
27. Anti-CD20 therapy in systemic lupus erythematosus: a step closer to the clinic.
Silverman GJ
Arthritis Rheum; 2005 Feb; 52(2):371-7. PubMed ID: 15692969
[No Abstract] [Full Text] [Related]
28. [New treatments for systemic diseases].
Bader-Meunier B; Willems M
Arch Pediatr; 2006 Jun; 13(6):596-8. PubMed ID: 16690273
[No Abstract] [Full Text] [Related]
29. Anticytokine therapy in systemic lupus erythematosus.
Yoo DH
Lupus; 2010 Oct; 19(12):1460-7. PubMed ID: 20947558
[TBL] [Abstract][Full Text] [Related]
30. Three different B-cell depletion (anti-CD20 monoclonal antibodies) treatments for severe resistant systemic lupus erythematosus.
Faria RM; Isenberg DA
Lupus; 2010 Sep; 19(10):1256-7. PubMed ID: 20534646
[No Abstract] [Full Text] [Related]
31. Comparative safety of therapies in systemic lupus erythematosus.
Mosak J; Furie R
Rheum Dis Clin North Am; 2012 Nov; 38(4):795-807. PubMed ID: 23137583
[TBL] [Abstract][Full Text] [Related]
32. [Systemic lupus and biotherapy: 2010 update].
Arnaud L; Amoura Z
Rev Med Interne; 2010 Dec; 31 Suppl 3():S296-303. PubMed ID: 21030117
[No Abstract] [Full Text] [Related]
33. Therapeutic CD154 antibody for lupus: promise for the future?
Kelsoe G
J Clin Invest; 2003 Nov; 112(10):1480-2. PubMed ID: 14617748
[TBL] [Abstract][Full Text] [Related]
34. B cells in SLE: different biological drugs for different pathogenic mechanisms.
Diamanti AP; Rosado MM; Carsetti R; Valesini G
Autoimmun Rev; 2007 Dec; 7(2):143-8. PubMed ID: 18035325
[TBL] [Abstract][Full Text] [Related]
35. Treating patients with lupus with B-cell depletion.
Isenberg DA
Lupus; 2008 May; 17(5):400-4. PubMed ID: 18490416
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of refractory skin manifestations of systemic lupus erythematosus with rituximab: report of a case.
Uthman I; Taher A; Abbas O; Menassa J; Ghosn S
Dermatology; 2008; 216(3):257-9. PubMed ID: 18182821
[No Abstract] [Full Text] [Related]
37. Belimumab for systemic lupus erythematosus: a practice-based view.
Parodis I; Axelsson M; Gunnarsson I
Lupus; 2013 Apr; 22(4):372-80. PubMed ID: 23553780
[TBL] [Abstract][Full Text] [Related]
38. A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): factors associated with B lymphocyte recovery.
Sutter JA; Kwan-Morley J; Dunham J; Du YZ; Kamoun M; Albert D; Eisenberg RA; Luning Prak ET
Clin Immunol; 2008 Mar; 126(3):282-90. PubMed ID: 18226586
[TBL] [Abstract][Full Text] [Related]
39. Biologic therapies in systemic lupus erythematosus.
Bernal CB; Zamora LD; Navarra SV
Int J Rheum Dis; 2015 Feb; 18(2):146-53. PubMed ID: 25884458
[TBL] [Abstract][Full Text] [Related]
40. Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?
Molloy ES; Calabrese LH
Autoimmun Rev; 2008 Dec; 8(2):144-6. PubMed ID: 18700172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
